Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jorge Hernández-Parada"'
Autor:
Francisco Gómez-García, Pedro Jesús Gómez-Arias, Ana Montilla-López, Jorge Hernández-Parada, Juan Luís Sanz-Cabanillas, Juan Ruano, Esmeralda Parra-Peralbo
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionThe Janus kinase–signal transducer and activator of transcription (JAK/STAT) pathway are known to be involved in inflammatory immune-mediated skin diseases, including psoriasis. The development of drugs targeting the JAK/STAT signaling
Externí odkaz:
https://doaj.org/article/282f88a0b2c14ad2ade96f7faa0bf80e
Autor:
Ana M. Montilla, Francisco Gómez-García, Pedro J. Gómez-Arias, Jesús Gay-Mimbrera, Jorge Hernández-Parada, Beatriz Isla-Tejera, Juan Ruano
Publikováno v:
Dermatology and Therapy, Vol 9, Iss 4, Pp 655-683 (2019)
Abstract Introduction The JAK/STAT signaling pathway is involved in the immune-mediated inflammatory skin diseases atopic dermatitis (AD), vitiligo, and alopecia areata (AA), and represents a potential target when developing treatments. So far, no dr
Externí odkaz:
https://doaj.org/article/932be4320b3e4bceb4c9a6db40a9c81e
Autor:
Beatriz Isla-Tejera, Juan Ruano, Ana Montilla, Jorge Hernández-Parada, Francisco Gómez-García, Pedro Jesús Gómez-Arias, Jesús Gay-Mimbrera
Publikováno v:
Dermatology and Therapy
Dermatology and Therapy, Vol 9, Iss 4, Pp 655-683 (2019)
Dermatology and Therapy, Vol 9, Iss 4, Pp 655-683 (2019)
Introduction The JAK/STAT signaling pathway is involved in the immune-mediated inflammatory skin diseases atopic dermatitis (AD), vitiligo, and alopecia areata (AA), and represents a potential target when developing treatments. So far, no drugs targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::184e5993e73e294a96cd8afb909c2147
https://doi.org/10.1007/s13555-019-00329-y
https://doi.org/10.1007/s13555-019-00329-y
Autor:
Juan Ruano, Francisco Gómez-García, Esmeralda Parra-Peralbo, Pedro Jesús Gómez-Arias, Ana María Montilla-López, Jorge Hernández-Parada
Publikováno v:
Dermatology and Therapy
Importance Type I interferon (IFN)-mediated monogenic autoinflammatory disorders (interferonopathies) are childhood-onset rare multisystemic diseases with limited treatment options. The Janus kinase (JAK) inhibitors are promising potential therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f802348df18e946bf0078f7f0aed1592
https://pubmed.ncbi.nlm.nih.gov/33856640
https://pubmed.ncbi.nlm.nih.gov/33856640
Publikováno v:
Dermatology Reports, Vol 12, Iss 1 (2020)
Imatinib mesylate is a small tyrosine kinase inhibitor that targets BCR-ABL, ckit and platelet-derived growth factor receptor. It is prescribed by hematologists for chronic myeloid leukemia and acute lymphoblastic leukemia and by oncologists for Gast
Externí odkaz:
https://doaj.org/article/b499375324fb49debdb561003083e4ba